High hydrostatic pressure extract of garlic increases the HDL cholesterol level via up-regulation of apolipoprotein A-I gene expression in rats fed a high-fat diet

Lipids in Health and Disease

Yangha Kim²  In-Hwan Kim³  Chong-Tai Kim¹  Hyunjin Joo²  Seohyun Lee² 

[1] Food Bio-Nano Research Group, Korea Food Research Institute, Seongnam, Gyeonggi, Republic of Korea;Department of Nutritional Science and Food Management, Ewha Womans University, Seoul, Republic of Korea;Department of Food and Nutrition, College of Health Science, Korea University, Seoul, Republic of Korea

关键词: Lecithin:cholesterol acyltransferase;    ATP-binding cassette transporter A1;    Apolipoprotein A-I;    Gene expression;    HDL-cholesterol;    High hydrostatic pressure processing;    Garlic;   

Others  :  1160272
DOI  :  10.1186/1476-511X-11-77

 received in 2012-02-29, accepted in 2012-06-09,  发布年份 2012

【 摘 要 】

Background

Cardiovascular disease (CVD) is the number one cause of mortality worldwide and a low high-density lipoprotein cholesterol (HDL-C) level is an important marker of CVD risk. Garlic (Allium sativum) has been widely used in the clinic for treatment of CVD and regulation of lipid metabolism. This study investigated the effects of a high hydrostatic pressure extract of garlic (HEG) on HDL-C level and regulation of hepatic apolipoprotein A-I (apoA-I) gene expression.

Methods

Male Sprague–Dawley rats were divided into two groups and maintained on a high-fat control diet (CON) or high-fat control diet supplemented with high hydrostatic pressure extract of garlic (HEG) for 5 weeks. Changes in the expression of genes related to HDL-C metabolism were analyzed in liver, together with biometric and blood parameters.

Results

In the HEG group, the plasma triglyceride (TG) and low-density lipoprotein cholesterol (LDL-C) levels were significantly decreased in comparison with the CON group (P < 0.05). Dietary HEG also lowered the hepatic TG and total cholesterol (TC) levels compared to the CON group. While the plasma HDL-C level and mRNA level of hepatic apoA-I, which is one of primarily proteins of HDL-C particle, were significantly increased in the HEG group compared to the CON group (P < 0.05). The gene expression of ATP-binding cassette transporter A1 (ABCA1) and lecithin:cholesterol acyltransferase (LCAT), importantly involved in the biogenesis in HDL, were also up-regulated by dietary HEG.

Conclusions

These results suggest that HEG ameliorates plasma lipid profiles and attenuates hepatic lipid accumulation in the high-fat fed rats. Our findings provides that the effects of HEG on the increase of the plasma HDL-C level was at least partially mediated by up-regulation of hepatic genes expression such as apoA-I, ABCA1, and LCAT in rats fed a high-fat diet.

【 授权许可】

   
2012 Lee et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Deaton C, Froelicher ES, Wu LH, Ho C, Shishani K, Jaarsma T: The global burden of cardiovascular disease. J Cardiovasc Nurs 2011, 26:S5-S14.
• [2]Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults: Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adults Treatment Panel III) Final report. 2001.
• [3]Kannel WB: Range of serum cholesterol values in the population developing coronary artery disease. Am J Cordiol 1995, 76:69C-77C.
• [4]Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR: High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977, 62:707-714.
• [5]Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB: Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 1986, 256:2835-2838.
• [6]Assmann G, Schulte H, von Eckardstein A, Huang Y: High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis 1996, 124:S11-S20.
• [7]Sharrett AR, Ballantyne CM, Coady SA, Heiss G, Sorlie PD, Catellier D, Patsch W: Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the atherosclerosis Risk in Communities (ARIC) Study. Circulation 2001, 104:1108-1113.
• [8]Asztalos BF: High-density lipoprotein particles, coronary heart disease, and niacin. J Clin Lipidol 2010, 4:405-410.
• [9]Zannis VI, Chroni A, Krieger M: Role of apoA-I, ABCA1, LCAT, and SR-Bi in the biogenesis of HDL. J Mol Med 2006, 84:276-294.
• [10]Mahmoodi M, Islami MR, Asadi Karam GR, Khaksari M, Sahebghadam Lotfi A, Hajizadeh MR, Mirzaee MR: Study of the effects of raw garlic consumption on the level of lipids and other blood biochemical factors in hyperlipidemic individuals. Pak J Pharm Sci 2006, 19:295-298.
• [11]Thomson M, Al-Qattan KK, Bordia T, Ali M: Including garlic in the diet may help lower blood glucose, cholesterol, and triglycerides. J Nutr 2006, 136:800S-802S.
• [12]Yeh YY, Yeh SM: Garlic reduced plasma lipids by inhibiting hepatic cholesterol and triacylglycerol synthesis. Lipids 1994, 29:189-193.
• [13]Kerckhoffs DA, Brouns F, Hornstra G, Mensink RP: Effects of the human serum lipoprotein profile of beta-glucan, soy protein and isoflavones, plant sterols and stanols, garlic and tocotrienols. J Nutr 2002, 132:2494-2505.
• [14]Lawson LD, Wang ZJ: Low allicin release from garlic supplements: a major problem due to the sensitivities of alliinase activity. J Agric Food Chem 2001, 49:2592-2599.
• [15]Tauscher B: Pasteurization of food by hydrostatic high pressure: chemical aspects. Zeitschrift für Lebensmitteluntersuchung und Forschung 1995, 200:3-13.
• [16]Ma Y, Song D, Wang Z, Jiang J, Jiang T, Cui F, Xiaobo F: Effect of ultrahigh pressure treatment on volatile compounds in garlic. Journal of food process engineering 2010, 34:1915-1930.
• [17]Kwon OC, Woo KS, Kim TM, Kim DJ, Hong JT, Jeong HS: Physicochemical characteristics of garlic (Allium sativum L) on the high temperature and pressure treatment. Korean J Food Sci Technol 2006, 38:331-336.
• [18]Yeh YY, Liu L: Cholesterol-lowering effect of garlic extracts and organosulfur compound: human and animal studies. J Nutr 2001, 131:989S-993S.
• [19]Stevinson C, Pittler MH, Ernst E: Garlic for treating hypercholesterolemia: a meta-analysis of randomized clinical trials. Ann Intern Med 2000, 133:420-429.
• [20]Koseoglu M, Isleten F, Atay A, Kaplan YC: Effects of acute and subacute garlic supplement administration on serum total antioxidant capacity and lipid parameters in healthy volunteers. Phytother Res 2010, 24:374-378.
• [21]Lee M, Kim I, Kim C, Kim Y: Reduction of body weight by dietary garlic is associated with increase in uncoupling protein mRNA expression and activation of AMP-Activated protein kinase in diet-induced obese mice. J Nutr 2011, 141:1947-1953.
• [22]Gebhardt R, Beck H, Wagner KG: Inhibition of cholesterol biosynthesis by allicin and ajoene in rat hepatocytes and HepG2 cells. Biochim Biophys Acta 1994, 1213:57-62.
• [23]Silagy C, Neil A: Garlic as a lipid lowering agent-a meta-analysis. J R Coll Physicians Lond 1994, 28:39-45.
• [24]Warshafsky S, Kamer RS, Sivak SL: Effect of garlic on total serum cholesterol. A meta-analysis. Ann Intern Med 1993, 119:599-605.
• [25]Ali M, Al-Qattan KK, Al-Enezi F, Khanafer RM, Mustafa T: Effect of allicin from garlic powder on serum lipids and blood pressure in rats fed high fat cholesterol diet. Prostaglandins Leukot Essent Fatty Acids 2000, 62:253-259.
• [26]Heidarian E, Jafari-Dehkordi E, Seidkhani-Nahal A: Effect of garlic on liver phosphatidate phosphohydrolase and plasma lipid levels in hyperlipidemic rats. Food Chem Toxicol 2011, 49:1110-1114.
• [27]Turley SD, Dietschy JM: The liver: Biology and Pathobiology. New York: Raven Press; 1998:617-641.
• [28]Bordia A, Verma SK, Srivastava KC: Effect of garlic (Allium sativum) on blood lipids, blood sugar, fibrinogen and fibrinolytic activity in patients with coronary artery disease. Prostaglandins Leukotrienes Essent. Fatty acids 1998, 58:257-263.
• [29]Fernandez ML, Webb D: The LDL to HDL cholesterol ratio as a valuable tool to evaluate coronary heart disease risk. J Am Coll Nutr 2008, 27:1-5.
• [30]Kwon MJ, Song YS, Choi MS, Park SJ, Jeong KS, Song YO: Cholesteryl ester transfer protein activity and atherogenic parameters in rabbits supplemented with cholesterol and garlic powder. Life Sci 2003, 72:2953-2964.
• [31]Lewis GF, Rader DJ: New insight into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res 2005, 96:1221-1232.
• [32]Walldius G, Jungner I, Holme I, Asatveit AH, Kolar W, Steiner E: High apolipoprotein B, Low apolipoprotein A-I, and improvement in the prediction of fetal myocardial infarction (AMORIS study): a prospective study. Lancet 2001, 358:2026-2033.
• [33]Phillips MC, Gillotte KL, Haynes MP, Johnson WJ, Lund-Katz S, Rothblat GH: Mechanism of high density lipoprotein-mediated efflux of cholesterol from cell plasma membrane. Atherosclerosis 1998, 137:S13-S17.
• [34]Azrolan N, Odaka H, Breslow JL, Fisher EA: Dietary fat elevates hepatic apoA-I production by increasing the fraction of apolipoprotein A-I mRNA in the translating pool. J Biol Chem 1995, 270:19833-19838.
• [35]Ahn YS, Smith D, Osada J, Li Z, Schaefer EJ, Ordovas JM: Dietary fat saturation affects apolipoprotein gene expression and high density lipoprotein size distribution in Golden Syrian hamsters. J Nutr 1994, 124:2147-2155.
• [36]Dorfman SE, Wang S, Vega-López S, Jauhiainen M, Lichtenstein AH: Dietary fatty acids and cholesterol differentially modulate HDL cholesterol metabolism in Golden-Syrian hamsters. J Nutr 2005, 135:492-499.
• [37]Ackermann RT, Mulrow CD, Ramirez G, Gardner CD, Morbidoni L, Lawrence VA: Garlic shows promise for improving some cardiovascular risk factors. Arch Intern Med 2001, 161:813-824.
• [38]Choi MS, Lee MK, Jung UJ, Kim HJ, Do GM, Park YB, Jeon SM: Metabolic response of soy pinitol on lipid-lowering, antioxidant and hepatoprotective action in hamsters fed-high fat and high cholesterol diet. Mol Nutr Food Res 2009, 53:751-759.
• [39]Reeves PG: Components of the AIN-93 diets as improvements in the AIN-76A diet. J Nutr 1997, 127:S838-S841.
• [40]Omodeo Salè F, Marchesini S, Fishman PH, Berra B: A sensitive enzymatic assay for determination of cholesterol in lipid extracts. Anal Biochem 1984, 142:347-350.
• [41]Rosenfeld L: Lipoprotein analysis. Early methods in the diagnosis of atherosclerosis. Arch Pathol Lab Med 1989, 113:1101-1110.
• [42]Bligh EG, Dyer WJ: A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959, 37:911-917.
• [43]Rozen S, Skaletsky HJ: Primer3 on the WWW for general users and for biologist programmers. In Bioinformatics methods and protocols: methods in molecular biology. Edited by Krawetz S, Misener S. Totowa (NJ): Humana Press; 2000:365-386.
• [44]Livak KJ, Schmittgent TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-△△CT method. Methods 2001, 25:402-408.